Markets:

Overview

News

Currencies

International

Treasuries

Biohaven Ltd. Common Shares (NY:BHVN)

9.930 -0.910 (-8.39%)

Official Closing Price Updated: 7:00 PM EST, Jan 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Biohaven Ltd. Common Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >

Biohaven Ltd. (BHVN): A High-Stakes Clinical Crossroad in Neuroscience and Immunology

December 26, 2025

As of December 26, 2025, Biohaven Ltd. (NYSE: BHVN) finds itself at a critical juncture. Once the darling of the biotech sector following a staggering $11.6 billion acquisition of its migraine...

Via PredictStreet

Topics Economy Intellectual Property

Stay updated with the stocks that are on the move in today's pre-market session. ↗

December 26, 2025

Discover the top movers in Friday's pre-market session and stay informed about market dynamics.

Via Chartmill

Biohaven’s Phase II Depression Trial Falls Short, But Analysts Downplay Impact – Wall Street Looks Ahead To Epilepsy Data ↗

December 26, 2025

William Blair expected challenges with the depression study, given difficulties in executing trials and the prevalence of placebo effects.

Via Stocktwits

Topics Artificial Intelligence

BHVN Stock Tumbled A Whopping 44% Today – What Did The FDA Letter Say? ↗

November 05, 2025

Via Stocktwits

Thursday's after hours session: top gainers and losers ↗

December 25, 2025

After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.

Via Chartmill

Which stocks are moving after the closing bell on Wednesday? ↗

December 24, 2025

As the regular session of the US market concludes on Wednesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

Biohaven Stock Slumps After Hours As Failed Depression Study Adds To A Brutal 2025 — Retail Eyes Epilepsy And Obesity Catalysts ↗

December 24, 2025

The company said that no reduction in depressive symptoms were observed in the BHV-7000 trial over six weeks as compared with placebo.

Via Stocktwits

Biohaven Insiders Bet $33 Million on a Turnaround ↗

November 20, 2025

Via MarketBeat

Biohaven's Chief Accounting Officer Scooped Up 17,000 Shares. Is the Stock a Buy? ↗

November 19, 2025

The Chief Accounting Officer added to his more than 85,000 shares held.

Via The Motley Fool

Topics Regulatory Compliance

Is Teladoc Stock a Buy After Oracle Investment Management Upped Its Stake? ↗

November 19, 2025

The investment company displayed confidence in Teladoc's growth potential by expanding its holdings in the stock.

Via The Motley Fool

FLEX LNG, Biohaven And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

November 12, 2025

Via Benzinga

Why LightPath Technologies Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket ↗

November 12, 2025

Via Benzinga

These stocks are moving in today's session ↗

November 05, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

Biohaven Stock Hits 52-Week Low, Cuts R&D Spending After FDA Rejection ↗

November 05, 2025

Biohaven stock plunged after the FDA rejected Vyglxia for spinocerebellar ataxia, prompting major R&D cuts and a William Blair downgrade.

Via Benzinga

Keep an eye on the top gainers and losers in Wednesday's session. ↗

November 05, 2025

Curious to know what's happening on the US markets in the middle of the day on Wednesday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 05, 2025

Via Benzinga

Crude Oil Down 1%; Solid Power Shares Spike Higher ↗

November 05, 2025

Via Benzinga

Wednesday's session: gap up and gap down stocks ↗

November 05, 2025

Let's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session.

Via Chartmill

Dow Surges 100 Points; McDonald's Posts Downbeat Earnings ↗

November 05, 2025

Via Benzinga

Topics Stocks

Biohaven Craters After FDA Unexpectedly Rejects Its High-Profile Drug ↗

November 05, 2025

The company was nearing approval for a treatment for a rare, neurodegenerative disease. Then, the FDA spoke.

Via Investor's Business Daily

Topics Earnings

Super Micro Computer Posts Downbeat Q1 Results, Joins Pinterest, Axon Enterprise And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

November 05, 2025

Via Benzinga

These stocks that are showing activity before the opening bell on Wednesday. ↗

November 05, 2025

The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 05, 2025

Via Benzinga

Why Teradata Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗

November 05, 2025

Via Benzinga

Discover the top movers in Monday's pre-market session. ↗

November 03, 2025

As we await the opening of the US market on Monday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Via Chartmill

Kimberly-Clark, Vertex And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

November 03, 2025

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 29, 2025

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

This Protagonist Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

September 17, 2025

Via Benzinga

Why Biohaven Stock Zoomed More Than 6% Higher Today ↗

August 22, 2025

It's always encouraging to get what appears to be good news from the FDA.

Via The Motley Fool

Topics Regulatory Compliance

Biohaven Surges After FDA Cancels Key Meeting. But Is It Good News? ↗

August 22, 2025

Biohaven stock surged early Friday after the FDA canceled an upcoming meeting to discuss the benefits and risks of its drug.

Via Investor's Business Daily

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.